Two-dose radiation could redefine prostate cancer treatment

A Rabin Medical Center study suggests prostate cancer patients could be treated with only two radiation doses instead of five, potentially changing the global standard of care. The ongoing trial of over 100 participants aims to preserve effectiveness and avoid increased side effects through highly focused, personalized radiotherapy, with early patient improvements reported amid Israel's relatively high incidence of prostate cancer.